Literature DB >> 30140992

Therapeutic Alliance and Anorexia Nervosa Treatment Outcomes: Experiences of Young People and Their Families.

Giuliana Mogorovich1, Nerina J Caltabiano2.   

Abstract

Treatments for anorexia nervosa provided early in the onset of the illness lead to better outcomes. Despite the treatment approach used, the therapeutic alliance may be instrumental in successful outcomes. The aim of this study was to explore the young people and their families' experiences of the illness, and their access to and satisfaction with the services received. Of particular interest was their view of the working alliance with their therapist/s. Participants were interviewed by telephone using a semi-structured questionnaire. Family based treatment or the Maudsley was found superior to other treatments with regard to physical markers of recovery, satisfaction with the services and therapy received, as well as the strength of the therapeutic alliance. All the interviewees stressed the need for more research, education, accessibility and flexibility of services and increased support for both the young people and their families.

Entities:  

Keywords:  Anorexia nervosa; Family based treatment; Maudsley; Therapeutic alliance; Treatment experiences; Working alliance

Mesh:

Year:  2018        PMID: 30140992     DOI: 10.1007/s10597-018-0327-8

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  19 in total

1.  Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review.

Authors:  D J Martin; J P Garske; M K Davis
Journal:  J Consult Clin Psychol       Date:  2000-06

2.  Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa.

Authors:  James Lock; Daniel Le Grange; W Stewart Agras; Ann Moye; Susan W Bryson; Booil Jo
Journal:  Arch Gen Psychiatry       Date:  2010-10

3.  Three psychotherapies for anorexia nervosa: a randomized, controlled trial.

Authors:  Virginia V W McIntosh; Jennifer Jordan; Frances A Carter; Suzanne E Luty; Janice M McKenzie; Cynthia M Bulik; Christopher M A Frampton; Peter R Joyce
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

Review 4.  A theoretical model of common process factors in youth and family therapy.

Authors:  Marc S Karver; Jessica B Handelsman; Sherecce Fields; Len Bickman
Journal:  Ment Health Serv Res       Date:  2005-03

Review 5.  Evidence-based treatment of anorexia nervosa.

Authors:  Christopher G Fairburn
Journal:  Int J Eat Disord       Date:  2005       Impact factor: 4.861

6.  Specialist supportive clinical management for anorexia nervosa.

Authors:  Virginia V W McIntosh; Jennifer Jordan; Suzanne E Luty; Frances A Carter; Janice M McKenzie; Cynthia M Bulik; Peter R Joyce
Journal:  Int J Eat Disord       Date:  2006-12       Impact factor: 4.861

7.  Role of therapeutic alliance in family therapy for adolescent anorexia nervosa.

Authors:  Tintina Pereira; James Lock; Jean Oggins
Journal:  Int J Eat Disord       Date:  2006-12       Impact factor: 4.861

Review 8.  Interventions for preventing eating disorders in children and adolescents.

Authors:  B M Pratt; S R Woolfenden
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 9.  Overview of treatment modalities in adolescent anorexia nervosa.

Authors:  Beate Herpertz-Dahlmann; Harriet Salbach-Andrae
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-01

10.  Enhanced cognitive behaviour therapy for adolescents with anorexia nervosa: an alternative to family therapy?

Authors:  Riccardo Dalle Grave; Simona Calugi; Helen A Doll; Christopher G Fairburn
Journal:  Behav Res Ther       Date:  2012-10-04
View more
  1 in total

1.  Adolescents with full or subthreshold anorexia nervosa in a naturalistic sample: treatment interventions and patient satisfaction.

Authors:  Katarina Lindstedt; Emma Forss; Marie Elwin; Lars Kjellin; Sanna Aila Gustafsson
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2020-05-02       Impact factor: 3.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.